comprehensive -WSS

comprehensive

author：hotspot 2025-09-30 14:58:35 - browse：2261

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday released a new accounting of artificial intelligence tools cleared for use in health care, adding scores of new products designed to reshape care in several areas of medicine.

The update included 171 new products that use artificial intelligence and machine learning, including 155 authorized since August of 2022. The agency’s data indicate that, after a lull during the Covid-19 pandemic, the number of authorized devices in 2023 is expected to increase by more than 30% over the prior year.

The list of AI devices was first published after a STAT investigation reported that the FDA had failed to keep the public informed on its regulation of AI devices, or crucial details on the tests undertaken to prove their safety and effectiveness. The summary documents that describe new AI devices often fail to break out the demographics of the patients they were tested on, or where the testing took place, which makes it difficult for clinicians and patients to understand their potential biases and weaknesses.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

leisure time

explore

WSS

Big Tobacco's 'harm reduction': Is it for real, or a sham?

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

Cytokinetics CEO stresses company can launch heart drug on its own

Gene therapy has helped boys walk. Can scientists keep it that way?

Colonoscopy at 40? Study finds a possible benefit

When prostate cancer spreads, where it goes matters

hotspot

comprehensive

explore

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Colonoscopy at 40? Study finds a possible benefit

New air purifier tech could be key to improving indoor air quality

Case highlights the risks of experimental stem cell therapy

The high cost of giving birth even with insurance

Colonoscopy at 40? Study finds a possible benefit

Walensky prepares to leave CDC — and Congress — behind

Gene therapy has helped boys walk. Can scientists keep it that way?

23andMe had bad news about my health. I wish a person had delivered it

Colonoscopy at 40? Study finds a possible benefit

hotspot

Why are elite athletes different? Take a look at their microbes

Wearables generate powerful data but its not useful to doctors, yet

STAT's guide to the next generation of CAR

Second House panel advances two

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

With FDA staff opposed to Sarepta therapy, top official intervened

leisure time

leisure time

explore

explore